Rocket Lab (NASDAQ:RKLB) Stock Price Up 1.6% Following Analyst Upgrade

Rocket Lab Corporation (NASDAQ:RKLBGet Free Report) was up 1.6% on Friday after Raymond James Financial upgraded the stock to a moderate buy rating. The company traded as high as $64.89 and last traded at $62.95. Approximately 15,253,261 shares traded hands during mid-day trading, a decline of 34% from the average session volume of 23,202,428 shares. The stock had previously closed at $61.96.

Other equities analysts have also recently issued reports about the company. Wall Street Zen cut Rocket Lab from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Morgan Stanley reiterated an “overweight” rating on shares of Rocket Lab in a research note on Wednesday, July 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of Rocket Lab in a research report on Friday, July 17th. Cantor Fitzgerald raised their price objective on shares of Rocket Lab from $96.00 to $122.00 and gave the company an “overweight” rating in a research note on Tuesday, August 11th. Finally, Citizens Jmp restated a “market outperform” rating and issued a $130.00 price objective on shares of Rocket Lab in a report on Tuesday, August 11th. Four research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Rocket Lab currently has a consensus rating of “Moderate Buy” and a consensus target price of $107.32.

Get Our Latest Research Report on Rocket Lab

Insider Transactions at Rocket Lab

In related news, insider Frank Klein sold 45,692 shares of the business’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $3,181,533.96. Following the completion of the transaction, the insider directly owned 961,295 shares of the company’s stock, valued at $66,934,970.85. The trade was a 4.54% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marvin Clevenger sold 15,051 shares of the company’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $1,048,001.13. Following the sale, the insider owned 458,924 shares in the company, valued at approximately $31,954,878.12. This trade represents a 3.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 3,624,371 shares of company stock valued at $312,944,881 in the last 90 days. Insiders own 8.40% of the company’s stock.

Key Stories Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

  • Positive Sentiment: Successful Electron launch supports near-term momentum. Rocket Lab deployed a confidential customer’s Earth-observation satellite into a 500-kilometer orbit. The mission was the company’s 95th Electron launch overall and its 16th this year, highlighting a reliable launch cadence in a capacity-constrained market. Another commercial launch is planned before the end of September. Rocket Lab Successfully Launches 16th Electron Mission
  • Positive Sentiment: Analysts see substantial upside potential. Raymond James identified two opportunities with significant upside, while multiple analysts maintain Strong Buy ratings and price targets well above the current trading level. The bullish case is supported by Rocket Lab’s record revenue, expanding backlog, and more than $1 billion in new contracts since the second quarter began. Why Raymond James Is Betting Big on Rocket Lab
  • Neutral Sentiment: The investment case depends on Neutron. Commentary argues Rocket Lab’s established launch and space-systems operations could justify taking the risk on its reusable Neutron medium-lift rocket. The company’s core business is improving, but Neutron’s development schedule has not changed, leaving investors focused on execution and potential delays. Rocket Lab’s Core Business Makes the Neutron Gamble Worth Taking
  • Negative Sentiment: Recent underperformance reflects company-specific concerns. RKLB declined sharply from mid-June through September 10 despite record revenue and new contracts, substantially underperforming major defense peers. The drop suggests investors remain concerned about Neutron execution, elevated expectations, and the stock’s high-risk valuation. What’s Behind the RKLB Drop?
  • Negative Sentiment: Insider selling is a notable overhang. Reported activity showed 97 insider sales and no purchases over the past six months, including substantial sales by CEO Peter Beck and other executives. This may reinforce concerns about valuation even as operating metrics improve.

Institutional Trading of Rocket Lab

Hedge funds have recently added to or reduced their stakes in the company. Palogic Value Management L.P. purchased a new position in Rocket Lab in the second quarter worth approximately $1,575,000. Sequoia Financial Advisors LLC increased its position in shares of Rocket Lab by 374.2% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 60,900 shares of the rocket manufacturer’s stock valued at $6,190,000 after purchasing an additional 48,057 shares during the last quarter. IPG Investment Advisors LLC increased its position in shares of Rocket Lab by 38.7% in the 2nd quarter. IPG Investment Advisors LLC now owns 9,106 shares of the rocket manufacturer’s stock valued at $926,000 after purchasing an additional 2,540 shares during the last quarter. National Pension Service raised its holdings in shares of Rocket Lab by 38.0% in the 2nd quarter. National Pension Service now owns 953,796 shares of the rocket manufacturer’s stock valued at $96,953,000 after purchasing an additional 262,410 shares in the last quarter. Finally, WINTON GROUP Ltd purchased a new stake in shares of Rocket Lab during the 2nd quarter worth $36,187,000. Institutional investors and hedge funds own 71.78% of the company’s stock.

Rocket Lab Trading Up 1.6%

The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. The company’s 50-day moving average price is $71.58 and its 200-day moving average price is $84.45. The firm has a market capitalization of $37.67 billion, a PE ratio of -233.14 and a beta of 2.60.

Rocket Lab (NASDAQ:RKLBGet Free Report) last posted its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The business had revenue of $234.07 million during the quarter, compared to analysts’ expectations of $231.62 million. On average, sell-side analysts expect that Rocket Lab Corporation will post -0.2 earnings per share for the current year.

About Rocket Lab

(Get Free Report)

Rocket Lab USA, Inc is a space company that provides launch services and space systems for commercial, civil and national security customers. The company develops and operates launch vehicles, spacecraft and satellite components, with activities spanning the design, manufacture and operation of space hardware.

Rocket Lab’s Electron rocket is a small-lift orbital launch vehicle designed to deploy small satellites. The company also develops HASTE, a suborbital test vehicle based on Electron technology, and is developing Neutron, a larger reusable launch vehicle intended to support a broader range of missions.

Featured Articles

Receive News & Ratings for Rocket Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Lab and related companies with MarketBeat.com's FREE daily email newsletter.